Filing Details
- Accession Number:
- 0001415889-25-002024
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-01-24 16:15:08
- Reporting Period:
- 2024-01-04
- Accepted Time:
- 2025-01-24 16:15:08
- Original Submission Date:
- 2024-01-08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1664710 | Keros Therapeutics Inc. | KROS | Pharmaceutical Preparations (2834) | 811173868 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682068 | Keith Regnante | C/O Keros Therapeutics, Inc. 1050 Waltham Street, Suite 302 Lexington MA 02421 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-04 | 40,000 | $16.00 | 40,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-04 | 40,000 | $45.29 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- This amendment is being filed to correct the Date of Earliest Transaction and the Transaction Date of each transaction listed in Table I.
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2023.
Billionaire Hedge Funds
